FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:1976-1977 November 3, 2005 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

To the Editor: A 74-year-old man presented with progressive and severe dyspnea of two months' duration. The patient had Parkinson's disease that had initially been treated with levodopa, to which cabergoline had been added during the preceding four months. The physical examination was notable for increased jugular venous pressure, bilateral rales, and edema in both legs. On auscultation, a gallop rhythm and a 2/6 pansystolic murmur radiating to the axilla were noted. A chest radiograph showed mild cardiomegaly and signs of acute pulmonary edema. Electrocardiography demonstrated sinus rhythm at 80 beats per minute with left atrial enlargement. Transthoracic echocardiography revealed . . . [Full Text of this Article]

Related Letters:

Cabergoline and Mitral Regurgitation
Delgrange E., Pinero A., Marcos-Alberca P., Fortes J.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:420, Jan 26, 2006. Correspondence

This article has been cited by other articles:

• Kars, M, Pereira, A M, Bax, J J, Romijn, J A (2008). Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. Eur J Endocrinol 159: 363-367 [Abstract] [Full Text]  
• Kars, M., Delgado, V., Holman, E. R., Feelders, R. A., Smit, J. W. A., Romijn, J. A., Bax, J. J., Pereira, A. M. (2008). Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease after 8 Years of Dopamine Agonist Therapy for Prolactinoma. J. Clin. Endocrinol. Metab. 93: 3348-3356 [Abstract] [Full Text]  
• Lancellotti, P., Livadariu, E., Markov, M., Daly, A. F, Burlacu, M.-C., Betea, D., Pierard, L., Beckers, A. (2008). Cabergoline and the risk of valvular lesions in endocrine disease.. Eur J Endocrinol 159: 1-5 [Abstract] [Full Text]  
• Donnelly, K. B. (2008). Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases. Toxicol Pathol 36: 204-217 [Abstract] [Full Text]  
• Ryan, M., Slevin, J. T. (2007). Restless Legs Syndrome. Journal of Pharmacy Practice 20: 430-448 [Abstract]  
• Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., Garbe, E. (2007). Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation. NEJM 356: 29-38 [Abstract] [Full Text]  
• Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., Pezzoli, G. (2007). Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease. NEJM 356: 39-46 [Abstract] [Full Text]  
• Gillam, M. P., Molitch, M. E., Lombardi, G., Colao, A. (2006). Advances in the Treatment of Prolactinomas. Endocr. Rev. 27: 485-534 [Abstract] [Full Text]  
• Delgrange, E., Pinero, A., Marcos-Alberca, P., Fortes, J. (2006). Cabergoline and Mitral Regurgitation. NEJM 354: 420-420 [Full Text]